Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $76.8 million.

  • Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) fell 57.39% to $76.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.8 million, marking a year-over-year decrease of 57.39%. This contributed to the annual value of $77.0 million for FY2024, which is 384.45% down from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) is $76.8 million, which was down 57.39% from $76.7 million recorded in Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) peaked at $84.8 million during Q3 2021, and registered a low of $76.5 million during Q1 2025.
  • In the last 5 years, Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) had a median value of $81.4 million in 2023 and averaged $80.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first increased by 5.67% in 2021, then crashed by 505.18% in 2024.
  • Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $84.7 million in 2021, then dropped by 2.01% to $83.0 million in 2022, then fell by 3.5% to $80.1 million in 2023, then decreased by 3.84% to $77.0 million in 2024, then fell by 0.33% to $76.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $76.8 million for Q3 2025, versus $76.7 million for Q2 2025 and $76.5 million for Q1 2025.